Clinical Trial Update: Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating guanfacine extended-release for ADHD-associated insomnia was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Insomnia

Drugs mentioned

• Guanfacine Extended Release (guanfacine)

Snippet

Sponsor: Children's Specialized Hospital | Conditions: Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder | Phase 4 | Status: TERMINATED | Results posted: 2014-08-11